To determine the involvement of human cytomegalovirus (CMV) 
cerebrospinal fluid samples. Aliquots of 50 ,ul of cerebrospinal fluid, which had been taken carefully to avoid blood contamination and preserved at under -800C until treatment, was used as a template for the polymerase chain reaction. Before DNA extraction samples were thawed and then centrifuged slowly to remove cellular components and other sediment; the supernatant was then used. To extract DNA, the procedure involving either glass power'2 or polyethylene glycol'3 was employed.
A pair of oligonucleotide primers kindly provided by Iatron Laboratories (Chiba, Japan) was used. These primers (MIE primers) were selected from the CMV major immediate early gene exon 4 sequence, and the expected length of the amplified DNA product was 426 base pairs.12
The reaction mixture for the polymerase chain reaction consisted of 10 mmolI Trishydrochloric acid (pH 8 3), 50 mmolIl potassium chloride, 1-5 mmoVl magnesium chloride, 200 p.mol/l of each dNTP, 0-025 U/41 of Taq polymerase (all the latter components were from a GeneAmp polymerase chain reaction reagent kit; Perkin Elmer Cetus), 1 ,umol/l of each primer, and 10 ,ul of a sample. To avoid cross contamination, the reaction mixture (without the sample) was prepared as a 'master mix', and divided into individual tubes. Cellular DNA was extracted from human CMV laboratory strain Towne infected cells as described previously and used as a positive control. 14 The reproducibility of the results was confirmed in each sample.
Results CMV DNA was detected in the cerebrospinal fluid of four patients (table 2 and fig 1) . The details of these patients are given in the following section. CMV DNA was not detected in any of the control samples (table 3) . Three patients with acute CMV hepatitis (C 11, P8, and P9) lacked CMV DNA in the cerebrospinal fluid (tables 1 and 3) . Urinary secretion of CMV DNA was detected in six of eight control samples, and in eight of 22 
Discussion
Application of the polymerase chain reaction to mononuclear cells in blood donors demonstrated that this method was more sensitive for detecting human CMV infection than serology.17 18 The detection of CMV antigen and/or CMV DNA has been believed to be a true positive result despite a negative culture.'9-21 The polymerase chain reaction was also shown to be a reliable means of diagnosing central nervous system infections due to herpesvirus including CMV.2223 The specificity of the polymerase chain reaction, applied to cerebrospinal fluid, in detecting CMV central nervous system involvement was established in patients infected by HIV.2-6 Also in immunocompetent hosts, CMV encephalitis was diagnosed on the basis of CMV DNA in cerebrospinal fluid detected on the polymerase chain reaction.8
In the present study, human CMV DNA was not detected in the cerebrospinal fluid of the controls. Three patients with acute CMV hepatitis also had no CMV DNA in their cerebrospinal fluid. Invasion of CMV into the central nervous system must not always occur, even during the acute phase of CMV infection. Recently, the polymerase chain reaction revealed the persistence of genomic materials of herpes simplex virus within the human central nervous system even 17 years after acute encephalitis.24 The existence of CMV DNA in the cerebrospinal fluid of P42 indicated that the genomic material of CMV could persist in the central nervous system for at least four years. Detection of CMV DNA in the cerebrospinal fluid of P44 and P45 long after the probable CMV central nervous system invasion was possible.
Among The ratio of positive CMV DNA in the urine of the controls (6/8) was higher than that in neurologically affected patients (8/22) . However, the wide prevalence of asymptomatic CMV infection in Japan is known,31 and CMV DNA in the urine is supposed to indicate the reactivation of CMV. " I The present results may reflect this wide prevalence, and may not mean a higher ratio of CMV infection in the controls than in the patients. Interestingly, we detected CMV DNA in the cerebrospinal fluid of patients who did not excrete CMV DNA (P44) or CMV antigen (P43) in their urine. The clinical significance of the detection of CMV DNA seems to be greater when CMV DNA is detected in the cerebrospinal fluid than in the urine.
We demonstrated that invasion of CMV into the central nervous system does not occur, even during the acute phase of CMV infection. Detection of CMV DNA in the cerebrospinal fluid hardly occurs in neurologically unaffected conditions. We have discussed the possible close association of CMV with each illness of patients who had CMV DNA in their cerebrospinal fluid. Though the time of central nervous system invasion remains to be determined in each of our patients, to prove the aetiological role of CMV, the polymerase chain reaction must constitute a novel means of elucidating the pathogeneses in neurologically affected patients with an unknown origin based upon the results with conventional procedures.
By applying the polymerase chain reaction to the cerebrospinal fluid, the mode of invasion of CMV (or another virus) into the developing central nervous system can be clarified further. We conclude that the polymerase chain reaction is a new addition to the established techniques for diagnosing viral infections.32
